CN110013372A - 编制支撑架 - Google Patents
编制支撑架 Download PDFInfo
- Publication number
- CN110013372A CN110013372A CN201811582034.0A CN201811582034A CN110013372A CN 110013372 A CN110013372 A CN 110013372A CN 201811582034 A CN201811582034 A CN 201811582034A CN 110013372 A CN110013372 A CN 110013372A
- Authority
- CN
- China
- Prior art keywords
- support frame
- rigidity
- silk material
- diameter
- establishment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000463 material Substances 0.000 claims abstract description 278
- 229920000642 polymer Polymers 0.000 claims description 150
- 230000008859 change Effects 0.000 claims description 42
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 42
- 230000002829 reductive effect Effects 0.000 claims description 29
- 210000005259 peripheral blood Anatomy 0.000 claims description 16
- 239000011886 peripheral blood Substances 0.000 claims description 16
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 12
- 229920001244 Poly(D,L-lactide) Polymers 0.000 claims description 11
- 229920000954 Polyglycolide Polymers 0.000 claims description 9
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 8
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 3
- 238000005297 material degradation process Methods 0.000 claims description 2
- 230000007246 mechanism Effects 0.000 abstract description 45
- 239000003814 drug Substances 0.000 abstract description 43
- 229940079593 drug Drugs 0.000 abstract description 39
- 239000000835 fiber Substances 0.000 description 156
- 210000004204 blood vessel Anatomy 0.000 description 97
- 238000000034 method Methods 0.000 description 75
- 230000002792 vascular Effects 0.000 description 45
- 238000002156 mixing Methods 0.000 description 44
- 238000004873 anchoring Methods 0.000 description 39
- 230000008569 process Effects 0.000 description 33
- 238000006731 degradation reaction Methods 0.000 description 31
- 230000015556 catabolic process Effects 0.000 description 30
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 27
- 230000033001 locomotion Effects 0.000 description 27
- 230000003902 lesion Effects 0.000 description 26
- 238000004519 manufacturing process Methods 0.000 description 24
- 229910052751 metal Inorganic materials 0.000 description 23
- 239000002184 metal Substances 0.000 description 23
- 238000002513 implantation Methods 0.000 description 22
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 22
- 238000011282 treatment Methods 0.000 description 21
- 230000006835 compression Effects 0.000 description 20
- 238000007906 compression Methods 0.000 description 20
- 238000001125 extrusion Methods 0.000 description 20
- 239000000203 mixture Substances 0.000 description 19
- 230000009467 reduction Effects 0.000 description 19
- 238000000576 coating method Methods 0.000 description 15
- 230000001684 chronic effect Effects 0.000 description 14
- 238000013461 design Methods 0.000 description 14
- 229960003957 dexamethasone Drugs 0.000 description 14
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 14
- 238000009954 braiding Methods 0.000 description 13
- 239000011248 coating agent Substances 0.000 description 13
- 238000004804 winding Methods 0.000 description 13
- 238000000137 annealing Methods 0.000 description 12
- 239000003550 marker Substances 0.000 description 11
- 229910003460 diamond Inorganic materials 0.000 description 10
- 239000010432 diamond Substances 0.000 description 10
- 238000012856 packing Methods 0.000 description 10
- 230000004044 response Effects 0.000 description 10
- 238000006073 displacement reaction Methods 0.000 description 9
- 229920001610 polycaprolactone Polymers 0.000 description 9
- 239000004632 polycaprolactone Substances 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 210000001367 artery Anatomy 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000000670 limiting effect Effects 0.000 description 8
- 230000004048 modification Effects 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 8
- 208000004434 Calcinosis Diseases 0.000 description 7
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 description 7
- 230000002308 calcification Effects 0.000 description 7
- 229960005167 everolimus Drugs 0.000 description 7
- 238000009998 heat setting Methods 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 238000011068 loading method Methods 0.000 description 7
- 238000009941 weaving Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000036760 body temperature Effects 0.000 description 6
- 239000000084 colloidal system Substances 0.000 description 6
- 230000005012 migration Effects 0.000 description 6
- 238000013508 migration Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000004809 Teflon Substances 0.000 description 5
- 229920006362 Teflon® Polymers 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 210000004351 coronary vessel Anatomy 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000945 filler Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000011065 in-situ storage Methods 0.000 description 5
- 239000008188 pellet Substances 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 4
- FPVRUILUEYSIMD-RPRRAYFGSA-N [(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(OC(C)=O)[C@@]1(C)C[C@@H]2O FPVRUILUEYSIMD-RPRRAYFGSA-N 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 230000004323 axial length Effects 0.000 description 4
- 238000005452 bending Methods 0.000 description 4
- 230000007797 corrosion Effects 0.000 description 4
- 238000005260 corrosion Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 229960003657 dexamethasone acetate Drugs 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 210000001105 femoral artery Anatomy 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229920001903 high density polyethylene Polymers 0.000 description 4
- 239000004700 high-density polyethylene Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000010606 normalization Methods 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229910052697 platinum Inorganic materials 0.000 description 4
- -1 poly(trimethylene carbonate) Polymers 0.000 description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 description 4
- 230000011218 segmentation Effects 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000000013 bile duct Anatomy 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000004811 fluoropolymer Substances 0.000 description 3
- 229920002313 fluoropolymer Polymers 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 229910052741 iridium Inorganic materials 0.000 description 3
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 3
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 3
- 230000002045 lasting effect Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 229920001434 poly(D-lactide) Polymers 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 208000037803 restenosis Diseases 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 208000000884 Airway Obstruction Diseases 0.000 description 2
- 206010016717 Fistula Diseases 0.000 description 2
- 229910018487 Ni—Cr Inorganic materials 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229920002988 biodegradable polymer Polymers 0.000 description 2
- 239000004621 biodegradable polymer Substances 0.000 description 2
- 238000001815 biotherapy Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001715 carotid artery Anatomy 0.000 description 2
- VNNRSPGTAMTISX-UHFFFAOYSA-N chromium nickel Chemical compound [Cr].[Ni] VNNRSPGTAMTISX-UHFFFAOYSA-N 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 210000003811 finger Anatomy 0.000 description 2
- 230000003890 fistula Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000009477 glass transition Effects 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000007917 intracranial administration Methods 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 229910001092 metal group alloy Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 2
- 239000000622 polydioxanone Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000007634 remodeling Methods 0.000 description 2
- 229920006126 semicrystalline polymer Polymers 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000012781 shape memory material Substances 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- 230000004218 vascular function Effects 0.000 description 2
- 230000002227 vasoactive effect Effects 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Oxohexane Chemical compound CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 1
- RBMHUYBJIYNRLY-UHFFFAOYSA-N 2-[(1-carboxy-1-hydroxyethyl)-hydroxyphosphoryl]-2-hydroxypropanoic acid Chemical compound OC(=O)C(O)(C)P(O)(=O)C(C)(O)C(O)=O RBMHUYBJIYNRLY-UHFFFAOYSA-N 0.000 description 1
- 229940006015 4-hydroxybutyric acid Drugs 0.000 description 1
- 229910001316 Ag alloy Inorganic materials 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000034827 Neointima Diseases 0.000 description 1
- 235000003283 Pachira macrocarpa Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 229920001710 Polyorthoester Polymers 0.000 description 1
- 229910001362 Ta alloys Inorganic materials 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 240000001085 Trapa natans Species 0.000 description 1
- 235000014364 Trapa natans Nutrition 0.000 description 1
- 229910001080 W alloy Inorganic materials 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 229920006125 amorphous polymer Polymers 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000007233 catalytic pyrolysis Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 208000008487 fibromuscular dysplasia Diseases 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 238000005242 forging Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 230000003446 memory effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 208000030613 peripheral artery disease Diseases 0.000 description 1
- 239000004631 polybutylene succinate Substances 0.000 description 1
- 229920002961 polybutylene succinate Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 238000010094 polymer processing Methods 0.000 description 1
- 239000002952 polymeric resin Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000002254 renal artery Anatomy 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000009165 saligot Nutrition 0.000 description 1
- 229920000431 shape-memory polymer Polymers 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229960002930 sirolimus Drugs 0.000 description 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000009955 starching Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 239000002407 tissue scaffold Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 230000000283 vasomotion Effects 0.000 description 1
- 238000007794 visualization technique Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/9517—Instruments specially adapted for placement or removal of stents or stent-grafts handle assemblies therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L31/125—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L31/128—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing other specific inorganic fillers not covered by A61L31/126 or A61L31/127
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
- A61F2/966—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/826—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents more than one stent being applied sequentially
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0018—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/003—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time
- A61F2250/0031—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time made from both resorbable and non-resorbable prosthetic parts, e.g. adjacent parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0039—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cardiology (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Composite Materials (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361877910P | 2013-09-13 | 2013-09-13 | |
| US61/877,910 | 2013-09-13 | ||
| US201461945745P | 2014-02-27 | 2014-02-27 | |
| US61/945,745 | 2014-02-27 | ||
| CN201480050385.0A CN105530895B (zh) | 2013-09-13 | 2014-09-12 | 编制支撑架 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201480050385.0A Division CN105530895B (zh) | 2013-09-13 | 2014-09-12 | 编制支撑架 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110013372A true CN110013372A (zh) | 2019-07-16 |
Family
ID=51570935
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811582034.0A Pending CN110013372A (zh) | 2013-09-13 | 2014-09-12 | 编制支撑架 |
| CN201480050385.0A Expired - Fee Related CN105530895B (zh) | 2013-09-13 | 2014-09-12 | 编制支撑架 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201480050385.0A Expired - Fee Related CN105530895B (zh) | 2013-09-13 | 2014-09-12 | 编制支撑架 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10004834B2 (https=) |
| EP (2) | EP3043753B1 (https=) |
| JP (1) | JP2016535647A (https=) |
| CN (2) | CN110013372A (https=) |
| HK (1) | HK1221632A1 (https=) |
| WO (1) | WO2015038875A1 (https=) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111304495A (zh) * | 2020-03-12 | 2020-06-19 | 东南大学 | 一种医用锌合金支架及其生产方法 |
| CN114343917A (zh) * | 2021-04-29 | 2022-04-15 | 江苏博朗森思医疗器械有限公司 | 一种气管支架 |
| US12599492B2 (en) | 2020-07-06 | 2026-04-14 | Shanghai Flowdynamics Medical Technology Co., Ltd. | Axially compressible bare stent |
Families Citing this family (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8128677B2 (en) | 2007-12-12 | 2012-03-06 | Intact Vascular LLC | Device and method for tacking plaque to a blood vessel wall |
| US9265633B2 (en) | 2009-05-20 | 2016-02-23 | 480 Biomedical, Inc. | Drug-eluting medical implants |
| US8137396B2 (en) * | 2009-05-20 | 2012-03-20 | 480 Biomedical, Inc | Medical implant |
| US10653511B2 (en) | 2011-01-28 | 2020-05-19 | Merit Medical Systems, Inc. | Electrospun PTFE coated stent and method of use |
| PT3199126T (pt) * | 2011-03-09 | 2020-01-28 | Tepha Inc | Sistemas para mastopexia |
| US9724223B2 (en) * | 2011-05-27 | 2017-08-08 | Abbotcardiovascular Systems Inc. | Delivery system for a self expanding stent |
| JP6300732B2 (ja) | 2012-01-16 | 2018-03-28 | メリット・メディカル・システムズ・インコーポレイテッドＭｅｒｉｔ Ｍｅｄｉｃａｌ Ｓｙｓｔｅｍｓ，Ｉｎｃ． | 回転スパン材料で被覆した医療器具及びその製造方法 |
| US11541154B2 (en) | 2012-09-19 | 2023-01-03 | Merit Medical Systems, Inc. | Electrospun material covered medical appliances and methods of manufacture |
| US9827703B2 (en) | 2013-03-13 | 2017-11-28 | Merit Medical Systems, Inc. | Methods, systems, and apparatuses for manufacturing rotational spun appliances |
| WO2014159710A1 (en) | 2013-03-13 | 2014-10-02 | Merit Medical Systems, Inc. | Serially deposited fiber materials and associated devices and methods |
| ES2768654T3 (es) | 2013-07-11 | 2020-06-23 | Tepha Inc | Implantes absorbibles para cirugía plástica |
| CN103961194B (zh) * | 2014-05-21 | 2016-05-18 | 苏州茵络医疗器械有限公司 | 一种高回缩性血管支架输送系统 |
| US10080583B2 (en) * | 2014-12-12 | 2018-09-25 | Depuy Mitel, Llc | Dilator for accessing a joint space |
| JP6549717B2 (ja) * | 2015-01-12 | 2019-07-24 | マイクロベンション インコーポレイテッドＭｉｃｒｏｖｅｎｔｉｏｎ， Ｉｎｃ． | ステント |
| US9375336B1 (en) | 2015-01-29 | 2016-06-28 | Intact Vascular, Inc. | Delivery device and method of delivery |
| US9433520B2 (en) | 2015-01-29 | 2016-09-06 | Intact Vascular, Inc. | Delivery device and method of delivery |
| US9788942B2 (en) * | 2015-02-03 | 2017-10-17 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
| WO2016126524A1 (en) * | 2015-02-03 | 2016-08-11 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having tubular seal |
| DK3261589T3 (da) | 2015-02-26 | 2020-12-14 | Merit Medical Systems Inc | Lagdelte medicinske indretninger |
| US10327933B2 (en) * | 2015-04-28 | 2019-06-25 | Cook Medical Technologies Llc | Medical cannulae, delivery systems and methods |
| JP6582649B2 (ja) * | 2015-07-10 | 2019-10-02 | 株式会社オートネットワーク技術研究所 | シールド構造 |
| US10441447B2 (en) | 2015-09-11 | 2019-10-15 | Cook Medical Technologies Llc | Variable radial stiffness and variable diameter intraluminal device |
| JP6816127B2 (ja) * | 2015-09-18 | 2021-01-20 | テルモ株式会社 | 血管プロテーゼ |
| EP4327786A3 (en) * | 2015-09-18 | 2024-05-01 | Terumo Corporation | Pushable implant delivery system |
| USD836778S1 (en) | 2015-10-09 | 2018-12-25 | Tepha, Inc. | Three dimensional mastopexy implant |
| US10004617B2 (en) | 2015-10-20 | 2018-06-26 | Cook Medical Technologies Llc | Woven stent device and manufacturing method |
| US10631984B2 (en) | 2015-12-15 | 2020-04-28 | Neovasc Tiara Inc. | Transseptal delivery system |
| US10993824B2 (en) | 2016-01-01 | 2021-05-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
| WO2017141805A1 (ja) * | 2016-02-16 | 2017-08-24 | 株式会社Ｐｅｎｔａｓ | ステント |
| US10850010B2 (en) * | 2016-02-25 | 2020-12-01 | Pentas Inc. | Stent |
| WO2017154512A1 (ja) * | 2016-03-11 | 2017-09-14 | テルモ株式会社 | ステントおよびステントデリバリーシステム |
| JP6859808B2 (ja) * | 2016-06-20 | 2021-04-14 | 株式会社ジェイ・エム・エス | ステントデリバリーシステム |
| WO2018132254A1 (en) * | 2017-01-12 | 2018-07-19 | Tyrx, Inc. | Tube covering for an implantable device |
| CN106581752A (zh) * | 2017-01-23 | 2017-04-26 | 苏州大学 | 一种可降解药物缓释功能复合肠道支架及其制作方法 |
| WO2018137763A1 (en) * | 2017-01-25 | 2018-08-02 | B. Braun Melsungen Ag | Endoluminal device |
| US10940030B2 (en) | 2017-03-10 | 2021-03-09 | Serenity Medical, Inc. | Method and system for delivering a self-expanding stent to the venous sinuses |
| JP2020520389A (ja) * | 2017-05-16 | 2020-07-09 | エムボディ インコーポレイテッド | バイオポリマー組成物、足場及びデバイス |
| US11660218B2 (en) | 2017-07-26 | 2023-05-30 | Intact Vascular, Inc. | Delivery device and method of delivery |
| EP3446661B1 (en) | 2017-08-21 | 2021-12-29 | Cook Medical Technologies LLC | Braided stent crown geometry and flare |
| CN108784896B (zh) * | 2017-10-31 | 2024-04-05 | 杭州诺生医疗科技有限公司 | 房间隔造口装置、房间隔造口系统及其操作方法 |
| WO2019099863A1 (en) * | 2017-11-17 | 2019-05-23 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Scaffolds having material properties optimized for cardiac applications and uses thereof |
| CN108072591B (zh) * | 2017-12-04 | 2020-01-17 | 厦门理工学院 | 一种聚合物熔体在线拉伸的试样支架及其用途 |
| KR102233499B1 (ko) * | 2017-12-05 | 2021-03-29 | 한국생산기술연구원 | 3차원 섬유형 스캐폴드 |
| WO2019111270A1 (en) * | 2017-12-07 | 2019-06-13 | Meril Life Sciences Pvt Ltd | Braided scaffold and method of manufacturing thereof |
| US11065136B2 (en) | 2018-02-08 | 2021-07-20 | Covidien Lp | Vascular expandable devices |
| US11065009B2 (en) * | 2018-02-08 | 2021-07-20 | Covidien Lp | Vascular expandable devices |
| USD889654S1 (en) | 2018-02-09 | 2020-07-07 | Tepha, Inc. | Three dimensional mastopexy implant |
| ES2953544T3 (es) | 2018-02-09 | 2023-11-14 | Tepha Inc | Implante mamario de contorno completo |
| WO2019158628A1 (en) | 2018-02-15 | 2019-08-22 | Tricares SAS | Stent and replacement heart valve prosthesis with improved fixation features |
| EP3740168A1 (en) * | 2018-02-28 | 2020-11-25 | Cook Medical Technologies LLC | Woven stent device with capped ends and manufacturing method |
| WO2019188689A1 (ja) * | 2018-03-27 | 2019-10-03 | テルモ株式会社 | ステント |
| US11058566B2 (en) * | 2018-04-11 | 2021-07-13 | Medtronic Vascular, Inc. | Variable rate prosthesis delivery system providing prosthesis alterations |
| USD892329S1 (en) | 2018-07-03 | 2020-08-04 | Tepha, Inc. | Three dimensional mastopexy implant |
| EP3860506A4 (en) | 2018-10-02 | 2022-06-29 | Tepha, Inc. | Medical devices to limit movement of breast implants |
| AU2019355988B2 (en) * | 2018-10-05 | 2022-10-20 | W. L. Gore & Associates, Inc. | Constraining mechanisms for selective deployment and associated methods |
| US11191655B2 (en) * | 2018-11-04 | 2021-12-07 | Biosert Ltd. | Expanding stent |
| US11911302B2 (en) * | 2018-12-28 | 2024-02-27 | Sree Chitra Tirunal Institute For Medical Sciences And Technology | Self expanding flow diversion device with enhanced kink resistance and radial strength |
| CN109700581B (zh) * | 2018-12-29 | 2021-12-03 | 元心科技(深圳)有限公司 | 支架及支架系统 |
| US11083610B2 (en) * | 2019-01-08 | 2021-08-10 | Covidien Lp | Expandable stent delivery apparatus to cover an access site |
| WO2020157018A1 (en) * | 2019-01-28 | 2020-08-06 | Tricares SAS | Three part stent second generation |
| EP3917756A4 (en) | 2019-02-01 | 2023-05-10 | Embody Inc. | Microfluidic extrusion |
| CN113490471A (zh) * | 2019-02-21 | 2021-10-08 | 埃菲摩乐医疗股份有限公司 | 在标称直径上展现最大径向强度的可吸收的血管内装置 |
| AU2020233892A1 (en) | 2019-03-08 | 2021-11-04 | Neovasc Tiara Inc. | Retrievable prosthesis delivery system |
| US20220175561A1 (en) * | 2019-04-08 | 2022-06-09 | Vanderbilt University | Patent ductus arteriosus stent |
| WO2020231387A1 (en) | 2019-05-10 | 2020-11-19 | W. L. Gore & Associates, Inc. | Constraining mechanisms for selective deployment and associated methods |
| AU2019445546B2 (en) | 2019-05-10 | 2022-12-15 | W. L. Gore & Associates, Inc. | Constraining mechanisms for selective deployment and associated methods |
| CN109964846A (zh) * | 2019-05-14 | 2019-07-05 | 江苏农牧科技职业学院 | 一种可植入式动物运动监测设备、系统和方法 |
| US11779742B2 (en) | 2019-05-20 | 2023-10-10 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
| CN114206408A (zh) * | 2019-06-05 | 2022-03-18 | 施菲姆德控股有限责任公司 | 导管血泵及其使用和制造方法 |
| CN114556484A (zh) * | 2019-07-11 | 2022-05-27 | 克利夫兰临床基金会 | 用于基于模型的支架设计和放置的系统和方法 |
| US11622858B2 (en) | 2019-10-09 | 2023-04-11 | Medtronic CV Luxembourg S.a.r.l. | Valve delivery system including foreshortening compensator for improved positioning accuracy |
| EP4041141A4 (en) * | 2019-10-11 | 2023-09-27 | Efemoral Medical Inc. | RESORBABLE INTRAVASCULAR DEVICES THAT PROVIDE A DECREASE IN RADIAL VESSEL RIGIDITY OVER TIME |
| MX2022006292A (es) | 2019-11-25 | 2022-08-15 | Tepha Inc | Envolturas de implantes de mama que limitan el movimiento de los implantes de mama, y metodos relacionados. |
| CN113017949A (zh) * | 2019-12-25 | 2021-06-25 | 上海鸿脉医疗科技有限公司 | 编织支架及编织支架系统 |
| CN113116617B (zh) * | 2019-12-31 | 2022-08-19 | 元心科技(深圳)有限公司 | 可吸收外周支架及其制备方法 |
| CN112155814B (zh) * | 2020-09-27 | 2022-05-13 | 艾柯医疗器械(北京)有限公司 | 低致栓颅内血管编织支架及其处理方法 |
| US20240091035A1 (en) * | 2020-12-16 | 2024-03-21 | Koninklijke Philips N.V. | Braided stent |
| EP4297813A4 (en) | 2021-02-26 | 2025-01-15 | Merit Medical Systems, Inc. | FIBER CONSTRUCTS WITH PARTICLES OF THERAPEUTIC MATERIAL |
| WO2022243077A1 (en) * | 2021-05-18 | 2022-11-24 | Koninklijke Philips N.V. | Stent delivery system with selective stiffness control |
| CN118119363A (zh) * | 2021-10-12 | 2024-05-31 | 波士顿科学国际有限公司 | 可调整长度的支架 |
| CN114010367A (zh) * | 2021-12-08 | 2022-02-08 | 王沛 | 一种具有可变支撑力的人工血管 |
| CN114287989B (zh) * | 2021-12-24 | 2023-12-08 | 珠海通桥医疗科技有限公司 | 一种血流导向装置支架 |
| CN119421676A (zh) * | 2022-06-16 | 2025-02-11 | 星光心血管股份有限公司 | 可变直径支架 |
| CN116370008B (zh) * | 2023-04-24 | 2024-01-30 | 上海励楷科技有限公司 | 多节距编织支架 |
| CN120346024B (zh) * | 2025-06-24 | 2025-09-19 | 浙江归创医疗科技有限公司 | 覆膜支架和球囊扩张覆膜支架系统 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003057079A1 (en) * | 2002-01-04 | 2003-07-17 | Scimed Life Systems, Inc. | Prosthesis implantable in enteral vessels |
| US20060204556A1 (en) * | 2001-12-07 | 2006-09-14 | Cytori Therapeutics, Inc. | Cell-loaded prostheses for regenerative intraluminal applications |
| CN102727332A (zh) * | 2011-04-14 | 2012-10-17 | 朝日英达科株式会社 | 支架 |
| WO2013019851A1 (en) * | 2011-08-04 | 2013-02-07 | Cook Medical Technologies Llc | Non-woven helical wire stent |
| CN203059974U (zh) * | 2013-01-24 | 2013-07-17 | 威海维心医疗设备有限公司 | 颅内自膨胀阶段覆膜编织支架 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2079417C (en) | 1991-10-28 | 2003-01-07 | Lilip Lau | Expandable stents and method of making same |
| US5824037A (en) * | 1995-10-03 | 1998-10-20 | Medtronic, Inc. | Modular intraluminal prostheses construction and methods |
| GB9522332D0 (en) * | 1995-11-01 | 1996-01-03 | Biocompatibles Ltd | Braided stent |
| US6592617B2 (en) * | 1996-04-30 | 2003-07-15 | Boston Scientific Scimed, Inc. | Three-dimensional braided covered stent |
| US5718159A (en) * | 1996-04-30 | 1998-02-17 | Schneider (Usa) Inc. | Process for manufacturing three-dimensional braided covered stent |
| CA2229685C (en) * | 1997-02-27 | 2003-09-02 | Corvita Corporation | Modular endoluminal stent-grafts and methods for their use |
| US5980564A (en) * | 1997-08-01 | 1999-11-09 | Schneider (Usa) Inc. | Bioabsorbable implantable endoprosthesis with reservoir |
| DE60024592T2 (de) | 1999-02-01 | 2006-07-20 | Board of Regents, The University of Texas System, Austin | Gewebte intravaskuläre vorrichtung und verfahren zur herstellung |
| EP1455681B1 (en) | 2001-12-21 | 2014-09-17 | Salviac Limited | A support frame for an embolic protection device |
| US7029494B2 (en) * | 2002-02-08 | 2006-04-18 | Scimed Life Systems, Inc. | Braided modular stent with hourglass-shaped interfaces |
| US7052511B2 (en) * | 2002-04-04 | 2006-05-30 | Scimed Life Systems, Inc. | Delivery system and method for deployment of foreshortening endoluminal devices |
| US6971990B2 (en) * | 2003-04-14 | 2005-12-06 | Troy J. Ziegler | Propulsion mechanism for endoscopic systems |
| US7241308B2 (en) * | 2003-06-09 | 2007-07-10 | Xtent, Inc. | Stent deployment systems and methods |
| US7758625B2 (en) * | 2003-09-12 | 2010-07-20 | Abbott Vascular Solutions Inc. | Delivery system for medical devices |
| US20050288766A1 (en) | 2004-06-28 | 2005-12-29 | Xtent, Inc. | Devices and methods for controlling expandable prostheses during deployment |
| CA2936205C (en) * | 2006-01-13 | 2018-08-21 | C.R. Bard, Inc. | Stent delivery system |
| US20100114125A1 (en) * | 2008-10-30 | 2010-05-06 | Albrecht Thomas E | Method of remotely adjusting a satiation and satiety-inducing implanted device |
| KR101006972B1 (ko) * | 2009-02-19 | 2011-01-12 | 신경민 | 음식물 역류방지와 체내 분해가 가능한 스텐트 |
| US20110077731A1 (en) * | 2009-09-25 | 2011-03-31 | Abbott Cardiovascular Systems Inc. | Multiple stent delivery system |
| US8808353B2 (en) | 2010-01-30 | 2014-08-19 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds having a low crossing profile |
| US8568471B2 (en) | 2010-01-30 | 2013-10-29 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds |
| US9326870B2 (en) * | 2010-04-23 | 2016-05-03 | Medtronic Vascular, Inc. | Biodegradable stent having non-biodegradable end portions and mechanisms for increased stent hoop strength |
-
2014
- 2014-09-12 JP JP2016542812A patent/JP2016535647A/ja not_active Ceased
- 2014-09-12 EP EP14767282.8A patent/EP3043753B1/en not_active Not-in-force
- 2014-09-12 CN CN201811582034.0A patent/CN110013372A/zh active Pending
- 2014-09-12 EP EP18205657.2A patent/EP3494933A1/en not_active Withdrawn
- 2014-09-12 WO PCT/US2014/055363 patent/WO2015038875A1/en not_active Ceased
- 2014-09-12 CN CN201480050385.0A patent/CN105530895B/zh not_active Expired - Fee Related
- 2014-09-12 US US14/484,943 patent/US10004834B2/en not_active Expired - Fee Related
- 2014-09-12 HK HK16109984.1A patent/HK1221632A1/zh unknown
-
2018
- 2018-06-01 US US15/996,355 patent/US20180272044A1/en not_active Abandoned
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060204556A1 (en) * | 2001-12-07 | 2006-09-14 | Cytori Therapeutics, Inc. | Cell-loaded prostheses for regenerative intraluminal applications |
| WO2003057079A1 (en) * | 2002-01-04 | 2003-07-17 | Scimed Life Systems, Inc. | Prosthesis implantable in enteral vessels |
| CN102727332A (zh) * | 2011-04-14 | 2012-10-17 | 朝日英达科株式会社 | 支架 |
| WO2013019851A1 (en) * | 2011-08-04 | 2013-02-07 | Cook Medical Technologies Llc | Non-woven helical wire stent |
| CN203059974U (zh) * | 2013-01-24 | 2013-07-17 | 威海维心医疗设备有限公司 | 颅内自膨胀阶段覆膜编织支架 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111304495A (zh) * | 2020-03-12 | 2020-06-19 | 东南大学 | 一种医用锌合金支架及其生产方法 |
| US12599492B2 (en) | 2020-07-06 | 2026-04-14 | Shanghai Flowdynamics Medical Technology Co., Ltd. | Axially compressible bare stent |
| CN114343917A (zh) * | 2021-04-29 | 2022-04-15 | 江苏博朗森思医疗器械有限公司 | 一种气管支架 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016535647A (ja) | 2016-11-17 |
| EP3494933A1 (en) | 2019-06-12 |
| WO2015038875A1 (en) | 2015-03-19 |
| US20150081000A1 (en) | 2015-03-19 |
| CN105530895B (zh) | 2019-01-11 |
| EP3043753B1 (en) | 2018-12-26 |
| US10004834B2 (en) | 2018-06-26 |
| CN105530895A (zh) | 2016-04-27 |
| US20180272044A1 (en) | 2018-09-27 |
| HK1221632A1 (zh) | 2017-06-09 |
| EP3043753A1 (en) | 2016-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105530895B (zh) | 编制支撑架 | |
| US20240325177A1 (en) | Bidirectional stent and method of use thereof | |
| US12491292B2 (en) | Dissolvable or degradable adhesive polymer to prevent stent migration | |
| US8317857B2 (en) | Biodegradable self-expanding prosthesis | |
| US8303650B2 (en) | Biodegradable self-expanding drug-eluting prosthesis | |
| AU781199B2 (en) | Bioresorbable stent | |
| CN103930074B (zh) | 一种生物可降解药物支架的特殊设计 | |
| US20080208321A1 (en) | Polymeric stent and method of manufacture | |
| EP0894505A2 (en) | Bioabsorbable self-expanding stent | |
| JPH11197252A5 (https=) | ||
| WO2000013737A1 (en) | Stent for vessels | |
| US9814610B2 (en) | Stent with elongating struts | |
| US20230355848A1 (en) | Biocarpet: a low profile, mechanically optimized, and fully biodegradable endovascular device for treatment of peripheral vascular diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190716 |
|
| WD01 | Invention patent application deemed withdrawn after publication |